Assessment of the periodontal state in subjects with metabolic syndrome;Ocena stanu przyzȩbia u chorych na zespól metaboliczny

Polski Merkuriusz Lekarski

Volumn 26, Issue 156, 2009, Pages 620-625

  Kowalski, M ^a   Brocka, E ^a   Barylski, M ^a   Kowalczyk, E ^a   Pawlicki, L ^a   Kowalski, J ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Metabolic syndrome; Periodontal diseases; Prophylaxis

Indexed keywords

ADULT; AGED; ARTICLE; COMORBIDITY; FEMALE; HUMAN; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PERIODONTAL DISEASE; POLAND;

ADULT; AGED; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PERIODONTAL DISEASES; POLAND;

EID: 67651173281     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Abou-Raya S., Naeem A., Abou-El Kheir H.: Coronary artery disease and periodontal disease: is there a link? Angiology, 2002, 53, 141-148.
2. Banach J.: Postȩpowanie lekarsko-stomatologiczne. W: Choroby blony śluzowej jamy ustnej i przyzȩbia. Jańczuk Z., Banach J. (red.). PZWL, Warszawa 1998.
3. Beck J., Garcia R., Heiss G., Vokonas P.S., Offenbacher S.: Periodontal disease and cardiovascular disease. J. Periodontal., 1996, 67, 1123-1137.
4. Beckman J.S., Koppenol W.H.: Nitric oxide, superoxide and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol., 1996, 271, C1424-C1437.
5. Buhlin K., Gustafsson A., Hakansson J., Klinge B.: Oral health and cardiovascular disease in Sweden. Results of a national questionnaire survey. J. Clin. Periodontal., 2002, 29, 254-259.
6. Cai H., Harrison D.G.: Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res., 2000, 87, 840-844.
7. DeStefano F., Anda R.F., Kahn H.S., Williamson D.F., Russell C.M.: Dental disease and risk of coronary heart disease and mortality. BMJ, 1993, 306, 688-691.
8. Emingil G., Buduneli E., Aliyev A., Akilll A., Atilla G.: Association between periodon-tal disease and acute myocardial infarction. J. Periodontal., 2000, 71, 1882-1886.
9. Fain J.N., Madan A.K., Hiler M.L., Cheema P., Bahouth S.W.: Comparison of the re-lease of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinol., 2004, 145, 2273-2282.
10. Hansson G.K.: Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med., 2005, 352, 1685-1695.
11. Hyman J.J., Winn D.M., Reid B.C.: The role of cigarette smoking in the association between periodontal disease and coronary heart disease. J. Priodontol., 2002, 73, 988-994.
12. Janket S.J., Baird A.E., Chuang S.K., Jones J.A.: Meta-analysis of periodontal disease and risk of coronary heart disease and stroke. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2003, 95, 559-569.
13. Jańczuk Z., Banach J., Dembowska E., Górska R., Szymańska J., Ziȩtek M.: Praktyczna periodontologia kliniczna. Wydawnictwo Kwintesencja, 2004.
14. Jańczuk Z.: Epidemiologia chorób przyzȩbia. W: Choroby błony śluzowej jamy ustnej i przyzȩbia. Jańczuk Z., Banach J. (red.). PZWL, Warszawa 1998.
15. Jegier M., Smalc A., Ciesielski P., Jander S., Jegier B.: Evaluation of the dental status in patients referred for heart surgery - a preliminary report. Arch. Med. Sci., 2006, 2, 125-127.
16. Kowalski J., Rysz J.: Epidemiologia zespołu metabolicznego. W: Zespół metaboliczny - prewencja i leczenie. Kowalski J. (red.). Medycyna Plus s.c, Warszawa 2006.
17. Kowalski J.: Rozpoznanie zespołu metabolicznego. W: Zespól metaboliczny - prewencja i leczenie. Kowalski J. (red.). Medycyna Plus s.o., Warszawa 2006.
18. Kowalski M.: Ocena stanu blony śluzowej jamy ustnej, przyzȩbia i zȩbów u osób z przewlekłymi chorobami ukladu oddechowego. Rozprawa doktorská, UM, Lódź 2004.
19. Lerman A., Zeiher A.M.: Endothelial function: cardiac events. Circulation, 2005, 211, 363-368.
20. Libby P., Ridker P.M., Maseri A.: Inflammation and atherosclerosis. Circulation, 2002, 105, 1135-1143.
21. Libby P.: Inflammation in atherosclerosis. Nature, 2002, 420, 868-874.
22. Malthaner S.C., Moore S., Mills M. i wsp.: Investigation of the association between angiographically defined coronary artery disease and periodontal disease. J. Periodontal., 2002, 73, 1169-1179.
23. Mattila K.J., Nieminen M.S., Valtonen V.V. i wsp.: Association between dental health and acute myocardial infarction. BMJ, 1989, 298, 779-782.
24. Mattila K.J., Valtonen V.V., Nieminen M., Huttunen J.K.: Dental infection and the risk of a new coronary events: prospective study of patients with documented coronary artery disease. Clin. Infect. Disease, 1995, 20, 588-592.
25. Morrison H.I., Ellison L.F., Taylor G.W.: Periodontal disease and risk of fatal coronary heart and cerebrovascular diseases. J. Cardiovasc. Risk., 1999, 6, 7-11.
26. Paunio K., Impivaara O., Tiekso J., Maki J.: Missing teeth and ischemic heart disease in men aged 45-64 years. Eur. Heart J., 1993, 14, supl. K, 54-56.
27. Pearson TA., Blair S.N., Daniels S.R. i wsp.: AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Com-prehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation, 2002, 106, 388-391.
28. Scannapieco F.A., Ho A.W.: Potential associations between chronic respiratory disease and periodontal disease. Analysis of National Health and Nutrition Examination Survey III. J. Periodontal., 2001, 72, 50-56.
29. Wesołowska T., Chetstowski K., Millo B.: Associations of body mass and adiposity with inflammatory markers in male offspring with a familly history of cardiovascular diseases. Twins model. Gemell. Rev., 2005, 6(1), 79-87.
30. Wu T., Trevisan M., Genco R.J., Dorn J.P., Falkner K.L., Sempos C.T.: Periodontal disease as a risk factor for CVD, CHD, and stroke: The first National Health and Nutri-tion Examination Survey (NHANES I) and its follow-up study. Circulation, 1999, 99, 8, 1109 (abstract).
31. Xu H., Barnes G.T., Yang Q. i wsp.: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest., 2003, 112, 1821-1830.